Home' Australian Pharmacist : Australian Pharmacist March 2016 Contents Australian Pharmacist March 2016 I ©Pharmaceutical Society of Australia Ltd.
to be an independent predictor of
mortality in cardiac patients.
trials have produced variable effects
on blood pressure and lipids (100-200
mg CoQ10/ day) and while the current
research supports the use of CoQ10
in the secondary prevention of CVD
and the treatment of congestive heart
failure, large scale well powered trials
are required to confirm the effects
of CoQ10 in the primary prevention
Despite a lack of clear clinical guidelines,
given the relatively low risk and
potential advantages, many patients
may benefit from including CAMs in
their overall CVD management plan.
1. Australian Bureau of Statistics. Causes of Death, Australia
2012. ABS cat. no. 3303 .0 . Canberra: ABS; 2014 [updated
30 Mar 2015]. At: www.abs.gov.au/ausstats/abs@.nsf/
2. Department of Health. Cardiovascular Disease. Australian
Government; 2015 [updated 14 Jan 2015; cited 1 Feb 2016].
3. Peiris D. RACGP Clinical Guidelines: Cardiovascular disease
prevention. 2012 [cited 3 Feb 2016]. At: www.racgp.org.au/
4. Oates L. Dietary and Lifestyle Recommendations for a
Healthy Heart. Australian Pharmacist 2014;33(10):52–4 .
5. Canaway R, Manderson L. Quality of life, perceptions of
health and illness, and complementary therapy use among
people with type 2 diabetes and cardiovascular disease.
Journal of alternative and complementary medicine
6. Wang H, Blumberg JB, Chen CY, et al. Dietary modulators
of statin efficacy in cardiovascular disease and cognition.
Molecular aspects of medicine 2014;38:1–53.
7. Oates L. Complementary medicines for dyslipidaemia. Aust
Pharm 2016;35(1):40–3 .
8. Diamond DM, Ravnskov U. How statistical deception
created the appearance that statins are safe and effective
in primary and secondary prevention of cardiovascular
disease. Expert review of clinical pharmacology
9. Oh PC, Koh KK, Sakuma I, et al. Omega-3 fatty acid therapy
dose-dependently and significantly decreased triglycerides
and improved flow-mediated dilation, however, did not
significantly improve insulin sensitivity in patients with
hypertriglyceridemia. International journal of cardiology
10. von Schacky C. Omega-3 index and cardiovascular health.
11. Heart Foundation (Australia). Position statement:
Phytosterol/stanol enriched foods 2007. [updated
December 2009; cited 2 February 2016]. At: www.
12. Oates L. CoQ10 and Fish Oils. Aust Pharm 2010;29(10):860–3.
13. Littarru GP, Tiano L. Clinical aspects of coenz yme Q10: an
update. Nutrition (Burbank, Los Angeles County, Calif )
14. Flowers N, Hartley L, Todkill D, et al. Co-enz yme Q10
supplementation for the primary prevention of
cardiovascular disease. The Cochrane database of
systematic reviews 2014;12:Cd010405.
This column is supported through an unrestricted
grant from Flordis.
clinically proven natural medicines
The first pharmacists have
undergone immunisation training
in Tasmania to enable them to
provide vaccinations for the
coming flu season.
In a win for pharmacists and
the community, the Tasmanian
Government last month reformed
health regulations to enable trained
pharmacists to administer flu vaccines
in approved sites across Tasmania.
Demand for pharmacist immunisation
training has soared across Australia,
according to the latest vaccination
education statistics from the PSA.
Around 1,260 pharmacists registered
for PSA training from the middle of
2014 to 1 February, in the wake of
recent legislative changes in several
states, enabling pharmacists to deliver
high-quality immunisation services
PSA Tasmanian Branch President Rachel
Dienaar said following an amendment
to Poisons Regulations, the first group
of pharmacists underwent training
‘ The PSA’s training will ensure
pharmacists in Tasmania will be ready
to administer flu vaccinations in time
for the 2016 flu season,’ Ms Dienaar said.
With the 2015 flu season being one
of the worst on record in Tasmania,
Ms Dienaar said pressure would be
eased on the local health system as
pharmacists prepare to vaccinate.
Influenza had a significant impact on
the state’s health system last year with
‘ This positive health outcome for
Tasmania has occurred thanks to
the support of State Health Minister
Mark Naunton receives his ‘flu vaccination’ from
Dr Sam Kosari at the ACT vaccination training held
Michael Ferguson and the Pharmacy
Guild of Australia,’ Ms Dienaar said.
Already 80 pharmacists in Tasmania
have signed up for the PSA training.
The PSA training courses, which have
already been run in Victoria, SA, WA,
NSW and Queensland, are based on the
training used internationally by more
than 150,000 pharmacists and in the
highly successful Queensland Pharmacy
The PSA’s vaccination training program
comprises two parts: online pre-reading,
and face-to-face workshops, which have
been held across the country.
Pharmacist-given flu vax to
start in Tasmania
Links Archive Australian Pharmacist February 2016 Australian Pharmacist April 2016 Navigation Previous Page Next Page